Jenise Wong, MD, PhD

Pediatric endocrinologist

Dr. Jenise Wong is a pediatric endocrinologist at the UCSF Madison Clinic for Pediatric Diabetes. She cares for children with type 1 and type 2 diabetes and those with a wide range of endocrine conditions, including thyroid, growth, pubertal and adrenal disorders.

Wong's research aims to understand the impact of new technologies, such as insulin pumps, continuous glucose monitoring devices and mobile phone and internet applications on a patient's ability to understand and self-manage type 1 diabetes and on their health outcomes. Wong aims to create innovative ways to make information from diabetes devices more accessible and actionable to patients, their caregivers and health care providers.

Wong earned a doctoral degree in genetics from Harvard University and medical degree from Stanford University School of Medicine. Subsequently, she completed an internship in pediatrics at UCSF and residency in pediatrics at Children's Hospital Boston and Boston Medical Center. Wong then completed a pediatric endocrinology fellowship and postdoctoral research at UCSF, where she is currently pursuing a master's of advanced studies in clinical research. She received a research fellowship award from the Pediatric Endocrine Society and a research grant from Genentech Center for Clinical Research. Wong is an assistant adjunct professor in pediatrics in the division of endocrinology at UCSF.


Madison Clinic for Pediatric Diabetes
1500 Owens St., Suite 300
San Francisco, CA 94158
Phone: (415) 514-6234
Fax: (415) 353-2811

Conditions & Treatments

More about Jenise Wong


Harvard University
Stanford University School of Medicine 2006


Children's Hospital of Boston/Boston Medical Center, Pediatrics 2009


UCSF Medical Center, Pediatric Endocrinology 2011

Selected Research and Publications

  1. Klonoff DC, Kerr D, Wong JC, Pavlovic Y, Koliwad S, Hu J, Salber P, Aguilera A, Long W, Hamilton G, Chen KY, Adi S. Digital Diabetes Congress 2017. J Diabetes Sci Technol. 2017 Sep; 11(5):1045-1052.
  2. Wong JC, Neinstein AB, Look H, Arbiter B, Chokr N, Ross C, Adi S. Pilot Study of a Novel Application for Data Visualization in Type 1 Diabetes. J Diabetes Sci Technol. 2017 Jul; 11(4):800-807.
  3. Wong JC, Boyle C, DiMeglio LA, Mastrandrea LD, Abel KL, Cengiz E, Cemeroglu PA, Aleppo G, Largay JF, Foster NC, Beck RW, Adi S. Evaluation of Pump Discontinuation and Associated Factors in the T1D Exchange Clinic Registry. J Diabetes Sci Technol. 2017 Mar; 11(2):224-232.
  4. Neinstein A, Wong J, Look H, Arbiter B, Quirk K, McCanne S, Sun Y, Blum M, Adi S. A case study in open source innovation: developing the Tidepool Platform for interoperability in type 1 diabetes management. J Am Med Inform Assoc. 2016 Mar; 23(2):324-32.
  5. Wong JC, Neinstein AB, Spindler M, Adi S. A Minority of Patients with Type 1 Diabetes Routinely Downloads and Retrospectively Reviews Device Data. Diabetes Technol Ther. 2015 Aug; 17(8):555-62.
  6. Redondo MJ, Foster NC, Libman IM, Mehta SN, Hathway JM, Bethin KE, Nathan BM, Ecker MA, Shah AC, DuBose SN, Tamborlane WV, Hoffman RP, Wong JC, Maahs DM, Beck RW, DiMeglio LA. Prevalence of cardiovascular risk factors in youth with type 1 diabetes and elevated body mass index. Acta Diabetol. 2016 Apr; 53(2):271-7.
  7. Wong JC, Foster NC, Maahs DM, Raghinaru D, Bergenstal RM, Ahmann AJ, Peters AL, Bode BW, Aleppo G, Hirsch IB, Kleis L, Chase HP, DuBose SN, Miller KM, Beck RW, Adi S. Response to comment on Wong et al. Real-time continuous glucose monitoring among participants in the T1D exchange clinic registry. Diabetes Care 2014;37:2702-2709. Diabetes Care. 2015 Apr; 38(4):e61.
  8. Wong JC, Dolan LM, Yang TT, Hood KK. Insulin pump use and glycemic control in adolescents with type 1 diabetes: Predictors of change in method of insulin delivery across two years. Pediatr Diabetes. 2015 Dec; 16(8):592-9.
  9. Wong JC, Foster NC, Maahs DM, Raghinaru D, Bergenstal RM, Ahmann AJ, Peters AL, Bode BW, Aleppo G, Hirsch IB, Kleis L, Chase HP, DuBose SN, Miller KM, Beck RW, Adi S. Real-time continuous glucose monitoring among participants in the T1D Exchange clinic registry. Diabetes Care. 2014 Oct; 37(10):2702-9.
  10. Campbell MS, Schatz DA, Chen V, Wong JC, Steck A, Tamborlane WV, Smith J, Beck RW, Cengiz E, Laffel LM, Miller KM, Haller MJ. A contrast between children and adolescents with excellent and poor control: the T1D Exchange clinic registry experience. Pediatr Diabetes. 2014 Mar; 15(2):110-7.
  11. Cengiz E, Xing D, Wong JC, Wolfsdorf JI, Haymond MW, Rewers A, Shanmugham S, Tamborlane WV, Willi SM, Seiple DL, Miller KM, DuBose SN, Beck RW. Severe hypoglycemia and diabetic ketoacidosis among youth with type 1 diabetes in the T1D Exchange clinic registry. Pediatr Diabetes. 2013 Sep; 14(6):447-54.
  12. Palmer RE, Lee SB, Wong JC, Reynolds PA, Zhang H, Truong V, Oliner JD, Gerald WL, Haber DA. Induction of BAIAP3 by the EWS-WT1 chimeric fusion implicates regulated exocytosis in tumorigenesis. Cancer Cell. 2002 Dec; 2(6):497-505.
  13. Wong JC, Lee SB, Bell MD, Reynolds PA, Fiore E, Stamenkovic I, Truong V, Oliner JD, Gerald WL, Haber DA. Induction of the interleukin-2/15 receptor beta-chain by the EWS-WT1 translocation product. Oncogene. 2002 Mar 27; 21(13):2009-19.
  14. Bönnemann CG, Wong J, Jones KJ, Lidov HG, Feener CA, Shapiro F, Darras BT, Kunkel LM, North KN. Primary gamma-sarcoglycanopathy (LGMD 2C): broadening of the mutational spectrum guided by the immunohistochemical profile. Neuromuscul Disord. 2002 Mar; 12(3):273-80.
  15. Lee SB, Huang K, Palmer R, Truong VB, Herzlinger D, Kolquist KA, Wong J, Paulding C, Yoon SK, Gerald W, Oliner JD, Haber DA. The Wilms tumor suppressor WT1 encodes a transcriptional activator of amphiregulin. Cell. 1999 Sep 03; 98(5):663-73.
  16. Chen JC, Tantamjarik P, Wong J. Hepatitis B Prevention in the Boston Asian American Community. Asian Am Pac Isl J Health. 1999; 7(2):180-184.
  17. Bönnemann CG, Wong J, Ben Hamida C, Hamida MB, Hentati F, Kunkel LM. LGMD 2E in Tunisia is caused by a homozygous missense mutation in beta-sarcoglycan exon 3. Neuromuscul Disord. 1998 May; 8(3-4):193-7.
  18. Maheswaran S, Englert C, Zheng G, Lee SB, Wong J, Harkin DP, Bean J, Ezzell R, Garvin AJ, McCluskey RT, DeCaprio JA, Haber DA. Inhibition of cellular proliferation by the Wilms tumor suppressor WT1 requires association with the inducible chaperone Hsp70. Genes Dev. 1998 Apr 15; 12(8):1108-20.
  19. Ueno AM, Vannais DB, Gustafson DL, Wong JC, Waldren CA. A low, adaptive dose of gamma-rays reduced the number and altered the spectrum of S1- mutants in human-hamster hybrid AL cells. Mutat Res. 1996 Nov 04; 358(2):161-9.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions to their publications by logging on to UCSF Profiles.